November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

November 19, 2024

Predicting ICH Causes: MRI Advantage

Conexiant

November 19, 2024

Novel Stroke Drug Shows 12-Hour Window

Despite a median treatment time of 9.5 hours after stroke onset - more than twice the current therapeutic window - JX10 showed significantly better functional outcomes than placebo with no symptomatic intracranial hemorrhage events.

Conexiant

November 18, 2024

Revised AF Guidelines for Dialysis Patients

"The components of the CHA2DS2-VASc score are so prevalent in HD patients with AF that most qualify for OAC if the guidelines are applied" - an observation from the study that challenges conventional risk assessment approaches for this high-risk population.

Conexiant

November 18, 2024

NSAIDs Double Bleeding Risk in VTE Patients

A recent study found that patients taking NSAIDs concurrently with oral anticoagulants had more than twice the bleeding risk compared with patients only taking anticoagulants.

Conexiant

November 15, 2024

First Aid Guidelines See Major Overhaul After 14 Years

None of the 179 first aid recommendations in the 2024 AHA/Red Cross guidelines achieved Level A evidence support, highlighting critical research gaps in foundational emergency care practices.

Conexiant

November 15, 2024

High BP at 40 Linked to 30-Year Stroke Risk

Women with systolic BP ≥140 mm Hg at age 40 face a striking 4x higher stroke risk over 30 years compared to those with optimal BP, new cohort study reveals.

Conexiant

November 13, 2024

Unique Genetic Risks Found for Aortic Stenosis

Conexiant

November 12, 2024

Lp(a) and LDL-C: Separate ASCVD Risk Factors

Conexiant